IL-23 cyclic peptide inhibitor 281

IL-23 cyclic peptide inhibitor 281, a cyclic peptide, is an IL-23 inhibitor. IL-23 cyclic peptide inhibitor 281 can be used for inflammatory disorders like inflammatory bowel disease (IBD) research[1].

Product Specifications

UNSPSC

12352209

Target

Interleukin Related

Related Pathways

Immunology/Inflammation

Field of Research

Inflammation/Immunology

Smiles

NC(C[C@@H](C(N[C@H](C(N(CC(N(C)C)=O)C)=O)CC1=CN=CC=C1)=O)NC([C@H](NC(C2(CCOCC2)NC([C@H](CC3=CC=C4C=CC=CC4=C3)NC([C@@H](NC([C@H]5NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)(SSC5(C)C)C)NC(C)=O)=O)CC(N(C)C)=O)=O)[C@@H](O)C)=O)CC6=CNC7=C(C=CC=C67)C)=O)CCCCN(C(C)=O)C)=O)=O)CC8=CC=C(C=C8)OCCCCC[N+](C)(C)C)=O)=O)=O)CCCCNC(C)=O)=O)=O.[Cl-]

Molecular Formula

C104H150ClN21O21S2

Molecular Weight

2130.01

References & Citations

[1]Hu QL, et al. Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory Disorders. ACS Med Chem Lett. 2025 Mar 27;16 (4) :532-533.